Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.fiercepharma.com/pharma/after-monumental-mash-nod-its-rezdiffra-madrigal-plots-600m-stock-sale-support-upcoming
https://www.globenewswire.com/news-release/2024/03/19/2848267/0/en/Madrigal-Pharmaceuticals-Announces-Pricing-of-Upsized-600-Million-Public-Offering.html
https://www.globenewswire.com/news-release/2024/03/18/2848146/0/en/Madrigal-Pharmaceuticals-Announces-Proposed-Public-Offering.html
https://www.cnbc.com/2024/03/14/fda-approves-nash-liver-disease-drug-from-madrigal-pharmaceuticals.html
https://endpts.com/madrigal-to-grapple-with-lack-of-awareness-about-nash-ahead-of-potential-fda-approval/
https://www.globenewswire.com//news-release/2024/03/06/2841769/0/en/Madrigal-Pharmaceuticals-Reports-Inducement-Grants-under-Nasdaq-Listing-Rule-5635-c-4.html
https://www.globenewswire.com//news-release/2024/03/05/2840401/0/en/Madrigal-Pharmaceuticals-Announces-EMA-Validation-of-its-Marketing-Authorization-Application-for-Resmetirom-for-the-Treatment-of-NASH-MASH-with-Liver-Fibrosis.html
https://www.globenewswire.com//news-release/2024/02/28/2836822/0/en/Madrigal-Pharmaceuticals-Appoints-Mardi-C-Dier-as-Chief-Financial-Officer.html
https://www.globenewswire.com//news-release/2024/02/28/2836803/0/en/Madrigal-Pharmaceuticals-Provides-Corporate-Updates-and-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results.html
https://www.globenewswire.com//news-release/2024/02/21/2832698/0/en/Madrigal-Pharmaceuticals-Reports-Inducement-Grants-under-Nasdaq-Listing-Rule-5635-c-4.html